to assess burden of SARS-CoV-2-infections in African adults in a setting with high HIV and TB prevalence

Grant number: INV-016202

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
  • Known Financial Commitments (USD)

    $880,490
  • Funder

    Gates Foundation
  • Research Location

    South Africa
  • Lead Research Institution

    Wits Health Consortium (Pty) Ltd
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies
  • Research Subcategory

    Disease surveillance & mapping
  • Special Interest Tags

    N/A
  • Study Type

    Non-Clinical
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Adults (18 and older)
  • Vulnerable Population

    Individuals with multimorbidity
  • Occupations of Interest

    Unspecified

Abstract

N/A

4 Publications linked via Europe PMC

Coronavirus Host Genomics Study: South Africa (COVIGen-SA).

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.

Clinical characteristics and histopathology of COVID-19 related deaths in South African adults.

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.